The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 1,097
- Locations
- 1
- Primary Endpoint
- Total triglycerides, mg/dL
Study Overview
Brief Summary
The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers.
The main questions it aims to answer are:
Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •be Arfa's company worker
Exclusion Criteria
- •individuals who were diagnosed with any type of cancer
Arms & Interventions
Arfa's company workers
all interventions administer to this arm
Intervention: nutritional interventions include education and modifying company's restaurant menu (Behavioral)
Outcomes
Primary Outcomes
Total triglycerides, mg/dL
Time Frame: From enrollment to the end of intervention at 6 months
Total Cholesterol, mg/dL
Time Frame: From enrollment to the end of intervention at 6 months
Low-density lipoprotein, mg/dL
Time Frame: From enrollment to the end of intervention at 6 months
High-density lipoprotein, mg/dl
Time Frame: From enrollment to the end of intervention at 6 months
Fast blood sugar, mg/dL
Time Frame: From enrollment to the end of intervention at 6 months
serum glutamic oxaloacetic transaminase, IU/L
Time Frame: From enrollment to the end of intervention at 6 months
serum glutamic pyruvic transaminase, IU/L
Time Frame: From enrollment to the end of intervention at 6 months
Secondary Outcomes
No secondary outcomes reported
Investigators
Peyman Sarsangi
Mr. Peyman Sarasangi, [Principal Investigator]
Shahid Sadoughi University of Medical Sciences and Health Services
